SCHEMBL21735520

SCHEMBL21735520

Oc1ccc2cc(-c3cccnc3)sc2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 10/20 0.69
ESR2 Q92731 10/20 0.69
CYP11B1 P15538 3/20 0.58
CYP11B2 P19099 3/20 0.58
CYP19A1 P11511 2/20 0.58
CYP3A4 P08684 3/20 0.51
CYP17A1 P05093 2/20 0.51
HDAC3 O15379 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
APP P05067 1/20 0.49
HSD17B1 P14061 2/20 0.48
HSD17B2 P37059 2/20 0.48
NPC1 O15118 1/20 0.47
MAPT P10636 1/20 0.47
RAB9A P51151 1/20 0.47
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7643423 0.82 ESR1 (1.00) ESR1ESR2APPHSD17B1HSD17B2
SCHEMBL1133139 0.80 HDAC3 (0.56) ESR1ESR2CYP11B1CYP11B2CYP19A1
Raloxifene Core SCHEMBL2567321 0.78 ESR1 (1.00) ESR1ESR2APPHSD17B1HSD17B2
Raloxifene Core SCHEMBL29941293 0.78 ESR1 (1.00) ESR1ESR2APPHSD17B1HSD17B2
SCHEMBL21735519 0.78 CYP11B2 (0.62) CYP11B1CYP11B2CYP19A1CYP3A4CYP17A1
SCHEMBL27364075 0.76 ESR1 (0.76) ESR1ESR2APPHSD17B1HSD17B2
SCHEMBL21166564 0.76 HDAC3 (0.52) CYP11B1CYP11B2CYP19A1CYP3A4CYP17A1
SCHEMBL30420821 0.76 RAB9A (0.66) CYP11B1CYP11B2CYP19A1APPNPC1
SCHEMBL21295783 0.74 HDAC3 (0.47) CYP11B1CYP11B2CYP19A1CYP3A4CYP17A1
SCHEMBL20911079 0.74 HDAC3 (0.50) CYP11B1CYP11B2CYP19A1CYP3A4CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11014901-B2 Hydrophobic compounds for optically active devices MERCK PATENT GMBH (DE) 2021-05-25 US disclosed
EP-3583091-B1 HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2020-11-04 EP disclosed
US-20200055833-A1 HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200055833-A1 HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES UACA, CRYZ, TRPA1 ESR1 1822/4885ESR2 3189/4885CYP11B1 2888/4885
US-11014901-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 ESR1 1822/4885ESR2 3189/4885CYP11B1 2888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.